These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11682776)

  • 1. Anti-HIV therapy update.
    Proj Inf Perspect; 2001 Mar; (32):4-6. PubMed ID: 11682776
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antiretroviral therapy in patients infected with HIV-1].
    Corti ME
    Medicina (B Aires); 1998; 58 Suppl 1():49-56. PubMed ID: 9674248
    [No Abstract]   [Full Text] [Related]  

  • 3. Another take on when to start and how to succeed.
    Friedland GH
    AIDS Clin Care; 2001 Sep; 13(9):82. PubMed ID: 11547600
    [No Abstract]   [Full Text] [Related]  

  • 4. When to start therapy--and what to start with.
    Gallant JE
    Posit Aware; 1997; 8(1):22-3. PubMed ID: 11364093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV: it's beginning to look like a chronic disease.
    del Rio C
    AIDS Clin Care; 2001 Sep; 13(9):82-3. PubMed ID: 11547601
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-HIV drug update.
    Proj Inf Perspect; 2000 Aug; (30):5-6. PubMed ID: 12171015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standard treatments for HIV, Spring 1997.
    Smith D
    AIDS Treat News; 1997 Apr; (No 269):4-5. PubMed ID: 11364255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term analysis of the resistance development in HIV-1 positive patients treated with protease and reverse transcriptase inhibitors: correlation of the genotype and disease progression.
    Václavíková J; Weber J; Machala L; Reinis M; Linka M; Brůcková M; Vandasová J; Stanková M; Konvalinka J
    Acta Virol; 2005; 49(1):29-36. PubMed ID: 15929396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicentre study to determine the efficacy and tolerability of a combination of nelfinavir (VIRACEPT), zalcitabine (HIVID) and zidovudine in the treatment of HIV infected Nigerian patients.
    Idoko JA; Akinsete L; Abalaka AD; Keshinro LB; Dutse L; Onyenekwe B; Lhekwaba A; Njoku OS; Kehinde MO; Wambebe CO
    West Afr J Med; 2002; 21(2):83-6. PubMed ID: 12403023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stavudine, lamivudine plus novel protease inhibitor therapy in antiretroviral-naive HIV-infected individuals treated for 24 weeks.
    Murphy RL
    Antivir Ther; 1999; 4 Suppl 3():85-7. PubMed ID: 16021877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virologic and immunologic responses to antiretroviral therapy among HIV-1 and HIV-2 dually infected patients: case reports from Abidjan, Côte d'Ivoire.
    Borget MY; Diallo K; Adje-Toure C; Chorba T; Nkengasong JN
    J Clin Virol; 2009 May; 45(1):72-5. PubMed ID: 19375979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on experimental antiretrovirals.
    Proj Inf Perspect; 2007 Oct; (44):8-19. PubMed ID: 18046833
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-HIV agents. Atazanavir as a booster for protease inhibitors.
    TreatmentUpdate; 2003; 15(4):1-2. PubMed ID: 17216850
    [No Abstract]   [Full Text] [Related]  

  • 14. Are nonnucleoside analogue-based regimens better than protease inhibitor-based regimens for nonadherent HIV-infected patients?
    Knobel H
    Clin Infect Dis; 2005 Jan; 40(1):164-6. PubMed ID: 15614707
    [No Abstract]   [Full Text] [Related]  

  • 15. Protease inhibitors: opium of the masses?
    Martinez LJ
    Res Initiat Treat Action; 2000 Sep; 6(3):7-11. PubMed ID: 11708167
    [No Abstract]   [Full Text] [Related]  

  • 16. The pipeline: three to watch.
    Hawes J
    BETA; 2004; 16(4):13-5. PubMed ID: 15386838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [HIV-infection: modern antiretroviral therapy].
    Rockstroh JK; Spengler U
    Dtsch Med Wochenschr; 2004 Sep; 129(37):1921-4. PubMed ID: 15372371
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination treatment -- study results.
    Treat Rev; 1996 Dec; (No 23):4-11. PubMed ID: 11364282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The initial patient visit: choosing an optimal antiretroviral strategy.
    Laurence J
    AIDS Read; 2000 Dec; 10(12):686-7. PubMed ID: 11189732
    [No Abstract]   [Full Text] [Related]  

  • 20. Patient adherence, not viral load now most important in HIV therapy.
    Rep Med Guidel Outcomes Res; 2000 Feb; 11(3):6-7. PubMed ID: 11768406
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.